Software - Application
Build Your Comparison
Side-by-side financial analysisStock Comparison
CYN vs MVST vs JPM vs BAC vs SES
Revenue, margins, valuation, and 5-year total return — side by side.
Electrical Equipment & Parts
Banks - Diversified
Banks - Diversified
Auto - Parts
CYN vs MVST vs JPM vs BAC vs SES — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Electrical Equipment & Parts | Banks - Diversified | Banks - Diversified | Auto - Parts |
| Market Cap | $14M | $376M | $896.00B | $422.78B | $345M |
| Revenue (TTM) | $276K | $372M | $280.33B | $191.57B | $22M |
| Net Income (TTM) | $-26M | $-43M | $57.05B | $30.51B | $-73M |
| Gross Margin | 34.4% | 26.4% | 60.0% | 56.1% | 36.3% |
| Operating Margin | -99.2% | -4.6% | 25.9% | 19.7% | -352.3% |
| Forward P/E | — | 10.3x | 14.4x | 12.6x | — |
| Total Debt | $7M | $186M | $942.38B | $365.90B | $8M |
| Cash & Equiv. | $990K | $105M | $343.34B | $231.84B | $30M |
CYN vs MVST vs JPM vs BAC vs SES — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | Jun 26 | Return |
|---|---|---|---|
| Cyngn Inc. (CYN) | 100 | 0.0 | -100.0% |
| Microvast Holdings,… (MVST) | 100 | 13.4 | -86.6% |
| JPMorgan Chase & Co. (JPM) | 100 | 188.8 | +88.8% |
| Bank of America Cor… (BAC) | 100 | 117.2 | +17.2% |
| SES AI Corporation (SES) | 100 | 10.4 | -89.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CYN vs MVST vs JPM vs BAC vs SES
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CYN is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 2.18, Low D/E 17.6%, current ratio 8.29x
MVST ranks third and is worth considering specifically for growth exposure.
- Rev growth 12.6%, EPS growth 85.2%, 3Y rev CAGR 27.9%
- Better valuation composite
JPM carries the broadest edge in this set and is the clearest fit for long-term compounding and valuation efficiency.
- 465.8% 10Y total return vs BAC's 368.2%
- PEG 0.81 vs BAC's 0.82
- NIM 2.2% vs BAC's 1.8%
- 20.4% margin vs CYN's -94.2%
BAC is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 12 yrs, beta 0.86, yield 2.3%
- Beta 0.86, yield 2.3%, current ratio 0.42x
- Beta 0.86 vs SES's 3.28
- +28.1% vs MVST's -73.1%
SES is the clearest fit if your priority is growth.
- 9.3% revenue growth vs CYN's -40.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.3% revenue growth vs CYN's -40.5% | |
| Value | Better valuation composite | |
| Quality / Margins | 20.4% margin vs CYN's -94.2% | |
| Stability / Safety | Beta 0.86 vs SES's 3.28 | |
| Dividends | 1.9% yield, 15-year raise streak, vs BAC's 2.3%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +28.1% vs MVST's -73.1% | |
| Efficiency (ROA) | 1.3% ROA vs CYN's -48.1%, ROIC 4.5% vs -117.2% |
CYN vs MVST vs JPM vs BAC vs SES — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
CYN vs MVST vs JPM vs BAC vs SES — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 3 of 6 categories
MVST leads 1 • BAC leads 1 • CYN leads 0 • SES leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 1014240.4x CYN's $276,397. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to CYN's -94.2%. On growth, CYN holds the edge at +121.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $276,397 | $372M | $280.3B | $191.6B | $22M |
| EBITDAEarnings before interest/tax | -$26M | $65M | $81.4B | $40.0B | -$67M |
| Net IncomeAfter-tax profit | -$26M | -$43M | $57.0B | $30.5B | -$73M |
| Free Cash FlowCash after capex | -$27M | $33M | $100.9B | $12.6B | -$58M |
| Gross MarginGross profit ÷ Revenue | +34.4% | +26.4% | +60.0% | +56.1% | +36.3% |
| Operating MarginEBIT ÷ Revenue | -99.2% | -4.6% | +25.9% | +19.7% | -3.5% |
| Net MarginNet income ÷ Revenue | -94.2% | -11.5% | +20.4% | +15.9% | -3.3% |
| FCF MarginFCF ÷ Revenue | -97.1% | +8.8% | +36.0% | +6.6% | -2.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +121.8% | -48.0% | — | — | +15.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +91.1% | +2.0% | +16.0% | +18.3% | -6.1% |
Valuation Metrics
MVST leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, BAC trades at a 8% valuation discount to JPM's 16.0x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs BAC's 0.95x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $14M | $376M | $896.0B | $422.8B | $345M |
| Enterprise ValueMkt cap + debt − cash | $19M | $457M | $1.50T | $556.8B | $324M |
| Trailing P/EPrice ÷ TTM EPS | -0.24x | -12.56x | 16.00x | 14.66x | -4.86x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.27x | 14.40x | 12.56x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.90x | 0.95x | — |
| EV / EBITDAEnterprise value multiple | — | 6.21x | 18.36x | 13.92x | — |
| Price / SalesMarket cap ÷ Revenue | 62.34x | 0.88x | 3.20x | 2.21x | 16.44x |
| Price / BookPrice ÷ Book value/share | 0.15x | 0.89x | 2.47x | 1.39x | 1.65x |
| Price / FCFMarket cap ÷ FCF | — | 6.71x | 8.88x | 33.52x | — |
Profitability & Efficiency
JPM leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-60 for CYN. SES carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), BAC scores 7/9 vs CYN's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -59.6% | -10.8% | +15.9% | +10.1% | -32.5% |
| ROA (TTM)Return on assets | -48.1% | -4.3% | +1.3% | +0.9% | -26.3% |
| ROICReturn on invested capital | -117.2% | +5.4% | +4.5% | +3.5% | -35.1% |
| ROCEReturn on capital employed | -71.5% | +7.1% | +8.9% | +4.5% | -29.7% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 5 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.18x | 0.45x | 2.60x | 1.21x | 0.04x |
| Net DebtTotal debt minus cash | $6M | $81M | $599.0B | $134.1B | -$21M |
| Cash & Equiv.Liquid assets | $990,023 | $105M | $343.3B | $231.8B | $30M |
| Total DebtShort + long-term debt | $7M | $186M | $942.4B | $365.9B | $8M |
| Interest CoverageEBIT ÷ Interest expense | -59.79x | -8.74x | 0.74x | 0.48x | — |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $0 for CYN. Over the past 12 months, BAC leads with a +28.1% total return vs MVST's -73.1%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs CYN's -95.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -54.9% | -59.9% | -0.5% | +1.1% | -44.3% |
| 1-Year ReturnPast 12 months | -72.6% | -73.1% | +21.8% | +28.1% | +7.6% |
| 3-Year ReturnCumulative with dividends | -100.0% | -23.6% | +138.2% | +103.0% | -49.3% |
| 5-Year ReturnCumulative with dividends | -100.0% | -91.4% | +118.2% | +47.1% | -89.4% |
| 10-Year ReturnCumulative with dividends | -100.0% | -88.4% | +465.8% | +368.2% | -90.0% |
| CAGR (3Y)Annualised 3-year return | -95.5% | -8.6% | +33.6% | +26.6% | -20.3% |
Risk & Volatility
BAC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BAC is the less volatile stock with a 0.86 beta — it tends to amplify market swings less than SES's 3.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BAC currently trades 97.3% from its 52-week high vs CYN's 3.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.18x | 2.52x | 0.94x | 0.86x | 3.28x |
| 52-Week HighHighest price in past year | $41.54 | $7.12 | $337.25 | $57.55 | $3.73 |
| 52-Week LowLowest price in past year | $1.22 | $1.07 | $262.71 | $43.66 | $0.80 |
| % of 52W HighCurrent price vs 52-week peak | +3.0% | +15.9% | +95.1% | +97.3% | +28.7% |
| RSI (14)Momentum oscillator 0–100 | 36.0 | 34.5 | 59.1 | 68.3 | 43.2 |
| Avg Volume (50D)Average daily shares traded | 277K | 4.3M | 7.0M | 31.7M | 8.8M |
Analyst Outlook
Evenly matched — JPM and BAC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MVST as "Buy", JPM as "Buy", BAC as "Buy", SES as "Hold". Consensus price targets imply 324.8% upside for MVST (target: $5) vs 5.9% for JPM (target: $340). For income investors, BAC offers the higher dividend yield at 2.26% vs JPM's 1.86%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $4.80 | $339.75 | $61.13 | $1.40 |
| # AnalystsCovering analysts | — | 6 | 61 | 54 | 4 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.9% | +2.3% | — |
| Dividend StreakConsecutive years of raises | 2 | — | 15 | 12 | — |
| Dividend / ShareAnnual DPS | — | — | $5.95 | $1.27 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +3.9% | +5.1% | +0.5% |
JPM leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MVST leads in 1 (Valuation Metrics). 1 tied.
CYN vs MVST vs JPM vs BAC vs SES: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CYN or MVST or JPM or BAC or SES a better buy right now?
For growth investors, SES AI Corporation (SES) is the stronger pick with 929.
4% revenue growth year-over-year, versus -40. 5% for Cyngn Inc. (CYN). Bank of America Corporation (BAC) offers the better valuation at 14. 7x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate Microvast Holdings, Inc. (MVST) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CYN or MVST or JPM or BAC or SES?
On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.
7x versus JPMorgan Chase & Co. at 16. 0x. On forward P/E, Microvast Holdings, Inc. is actually cheaper at 10. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Bank of America Corporation's 0. 82x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CYN or MVST or JPM or BAC or SES?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to -100. 0% for Cyngn Inc. (CYN). Over 10 years, the gap is even starker: JPM returned +465. 8% versus CYN's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CYN or MVST or JPM or BAC or SES?
By beta (market sensitivity over 5 years), Bank of America Corporation (BAC) is the lower-risk stock at 0.
86β versus SES AI Corporation's 3. 28β — meaning SES is approximately 279% more volatile than BAC relative to the S&P 500. On balance sheet safety, SES AI Corporation (SES) carries a lower debt/equity ratio of 4% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — CYN or MVST or JPM or BAC or SES?
By revenue growth (latest reported year), SES AI Corporation (SES) is pulling ahead at 929.
4% versus -40. 5% for Cyngn Inc. (CYN). On earnings-per-share growth, the picture is similar: Microvast Holdings, Inc. grew EPS 85. 2% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Over a 3-year CAGR, MVST leads at 27. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CYN or MVST or JPM or BAC or SES?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -107. 2% for Cyngn Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -117. 3% for CYN. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CYN or MVST or JPM or BAC or SES more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Bank of America Corporation's 0. 82x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Microvast Holdings, Inc. (MVST) trades at 10. 3x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 4. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MVST: 324. 8% to $4. 80.
08Which pays a better dividend — CYN or MVST or JPM or BAC or SES?
In this comparison, BAC (2.
3% yield), JPM (1. 9% yield) pay a dividend. CYN, MVST, SES do not pay a meaningful dividend and should not be held primarily for income.
09Is CYN or MVST or JPM or BAC or SES better for a retirement portfolio?
For long-horizon retirement investors, Bank of America Corporation (BAC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
86), 2. 3% yield, +368. 2% 10Y return). Cyngn Inc. (CYN) carries a higher beta of 2. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BAC: +368. 2%, CYN: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CYN and MVST and JPM and BAC and SES?
These companies operate in different sectors (CYN (Technology) and MVST (Industrials) and JPM (Financial Services) and BAC (Financial Services) and SES (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CYN is a small-cap quality compounder stock; MVST is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock; SES is a small-cap high-growth stock. JPM, BAC pay a dividend while CYN, MVST, SES do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.